{"entity":{"id":"fb9cb50d-b3fe-50df-94fa-b49873eaced0","name":"Zanganeh Mahkam","type":"Person","kind":"person","jurisdiction":"US","identifier":"sec:0001507650","risk":"LOW","flags":[]},"identity":{"linked_records":[],"also_known_in":[]},"ownership":{"direct_owners":[],"holdings":[{"role":"director","share":null,"asset":{"id":"d9670250-cf3e-5ed7-9418-8d8ded5fbde9","name":"PULSE BIOSCIENCES, INC.","type":"Company","kind":"company"}},{"role":"10% owner","share":null,"asset":{"id":"925c6d35-70e2-5e05-b993-e0b472b9bff1","name":"Summit Therapeutics Inc.","type":"Company","kind":"company"}}],"ubo_chain":[]},"risk":{"level":"LOW","flags":[],"note":"Risk is a layer-1 signal (offshore-layering / connectivity heuristics) — an investigative lead, not a determination."},"sources":[{"registry":"sec_edgar","source_url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001507650"}],"source":"corpus"}